Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
10.97
-0.52 (-4.49%)
At close: May 21, 2025, 4:00 PM
10.94
-0.03 (-0.23%)
After-hours: May 21, 2025, 4:00 PM EDT

Zenas BioPharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
196.55319.7456.8667.21
Short-Term Investments
115.8331.02--
Cash & Short-Term Investments
312.38350.7756.8667.21
Cash Growth
740.77%516.93%-15.40%-
Prepaid Expenses
3.733.071.651.24
Restricted Cash
-0.09--
Other Current Assets
-21.3-
Total Current Assets
317.81355.9259.868.44
Property, Plant & Equipment
1.281.191.011.8
Long-Term Deferred Charges
--1.39-
Other Long-Term Assets
12.8512.865.974.33
Total Assets
333.77369.9768.1874.58
Accounts Payable
20.0217.145.45.82
Accrued Expenses
28.239.1617.0119.44
Current Portion of Leases
0.910.790.560.72
Current Income Taxes Payable
0.010.210.3-
Total Current Liabilities
49.1357.2923.2625.97
Long-Term Debt
--20.3-
Long-Term Leases
0.320.220.260.81
Total Liabilities
49.4557.5143.8226.78
Common Stock
00-0
Additional Paid-In Capital
705.14699.654.651.03
Retained Earnings
-420.96-387.39-230.4-193.28
Comprehensive Income & Other
0.140.190.04-0.04
Total Common Equity
284.32312.46-225.72-192.29
Shareholders' Equity
284.32312.4624.3747.8
Total Liabilities & Equity
333.77369.9768.1874.58
Total Debt
1.23121.111.53
Net Cash (Debt)
311.15349.7635.7465.68
Net Cash Growth
1906.02%878.52%-45.58%-
Net Cash Per Share
13.3826.5023.3444.02
Filing Date Shares Outstanding
41.8341.81.581.55
Total Common Shares Outstanding
41.8241.791.581.55
Working Capital
268.68298.6336.5542.48
Book Value Per Share
6.807.48-143.15-124.11
Tangible Book Value
284.32312.46-225.72-192.29
Tangible Book Value Per Share
6.807.48-143.15-124.11
Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q